Department of Otolaryngology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.
Department of Gastroenterology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.
Chin J Integr Med. 2022 Aug;28(8):743-752. doi: 10.1007/s11655-022-3722-5. Epub 2022 Jul 30.
To evaluate the existing randomized controlled trials (RCTs) for evidence of the efficacy and safety of head acupuncture (HA) plus Schuell's language rehabilitation (SLR) in post-stroke aphasia.
Seven databases including Embase, PubMed, Cochrane Library, Technology Periodical Database, the China National Knowledge Infrastructure, SinoMed and Wanfang Data Information Site were searched for RCTs published from database inception until November 14, 2021. RCTs that compared HA plus SLR with sham (or blank) control, acupuncture therapy alone, certain language rehabilitation therapy alone or other therapies for post-stroke aphasia were included. Data were extracted and assessed, and the quality of RCTs was evaluated. Fixed-effects model was used, with meta-inflfluence analysis, meta-regression, and regression-based sub-group analyses applied for exploration of heterogeneity. Publication bias was estimated by funnel plots and Egger's tests.
A total of 32 RCTs with 1,968 patients were included and 51 comparisons were conducted classified as types of strokes and aphasia. (1) For patients with aphasia after ischemic stroke, HA plus PSA showed significantly higher accumulative markedly effective rate [relative risk (RR)=1.55, 95% confidence interval (CI): 1.19-2.02, I=0%] and accumulative effective rate (RR=1.22, 95% CI: 1.09-1.36, I=0%). (2) For patients with comprehensive types of stroke, HA plus PSA was more effective in increasing recovery rate (RR=1.89, 95% CI: 1.39-2.56, I=0%), accumulative markedly effective rate (RR=1.53, 95% CI: 1.36-1.72, I=9%) and accumulative effective rate (RR=1.14, 95% CI: 1.09-1.19, I=34%). (3) For patients with aphasia after stroke, HA plus PSA was superior to PSA alone with statistical significance in increasing recovery rate (RR=2.08, 95% CI: 1.24-3.46, I=0%), accumulative markedly effective rate (RR=1.49, 95% CI: 1.24-1.78, I=0%) and accumulative effective rate (RR=1.15, 95% CI: 1.06-1.24, I=39%). (4) For patients with multiple types of aphasia, HA plus PSA also demonstrated significantly higher recovery rate (RR=1.86, 95% CI: 1.28-2.72, I=0%), accumulative markedly effective rate (RR=1.55, 95% CI: 1.35-1.78, I=22%), and accumulative effective rate (RR=1.17, 95% CI: 1.11-1.23, I=41%). (5) For patients with motor aphasia after ischemic stroke, compared with PSA alone, HA plus PSA showed significantly higher accumulative markedly effective rate (RR=1.38, 95% CI: 1.06-1.79, I=0%) and accumulative effective rate (RR=1.20, 95% CI: 1.05-1.37, I=0%). Meta-regression analyses were performed without significant difference, and publication bias was found in some comparisons.
HA plus SLR was significantly associated with better language ability and higher effective rate for patients with post-stroke aphasia, and HA should be operated cautiously especially during acupuncture at eye and neck. (Registration No. CRD42020154475).
评估现有关于头针(HA)联合舒尔言语康复(SLR)治疗中风后失语症的随机对照试验(RCT)的疗效和安全性证据。
检索 Embase、PubMed、Cochrane 图书馆、中国科技期刊数据库、中国知网、中国生物医学文献数据库、万方数据知识服务平台,检索时间截至 2021 年 11 月 14 日,收集 HA 联合 SLR 与假对照、针刺疗法单独、特定语言康复疗法单独或其他疗法治疗中风后失语症的 RCT。提取和评估数据,并评价 RCT 的质量。采用固定效应模型,进行meta 影响分析、meta 回归和基于回归的亚组分析,以探索异质性。采用漏斗图和 Egger 检验估计发表偏倚。
共纳入 32 项 RCT,共 1968 例患者,分为中风类型和失语类型。(1)对于缺血性中风后失语患者,HA 联合 PSA 显著提高了累积显效率[相对危险度(RR)=1.55,95%置信区间(CI):1.19-2.02,I=0%]和累积有效率(RR=1.22,95% CI:1.09-1.36,I=0%)。(2)对于综合类型中风患者,HA 联合 PSA 更有利于提高恢复率(RR=1.89,95% CI:1.39-2.56,I=0%)、累积显效率(RR=1.53,95% CI:1.36-1.72,I=9%)和累积有效率(RR=1.14,95% CI:1.09-1.19,I=34%)。(3)对于中风后失语患者,HA 联合 PSA 与 PSA 单独治疗相比,在提高恢复率(RR=2.08,95% CI:1.24-3.46,I=0%)、累积显效率(RR=1.49,95% CI:1.24-1.78,I=0%)和累积有效率(RR=1.15,95% CI:1.06-1.24,I=39%)方面均有统计学意义。(4)对于多种类型失语患者,HA 联合 PSA 也显著提高了恢复率(RR=1.86,95% CI:1.28-2.72,I=0%)、累积显效率(RR=1.55,95% CI:1.35-1.78,I=22%)和累积有效率(RR=1.17,95% CI:1.11-1.23,I=41%)。(5)对于缺血性中风后运动性失语患者,与 PSA 单独治疗相比,HA 联合 PSA 显著提高了累积显效率(RR=1.38,95% CI:1.06-1.79,I=0%)和累积有效率(RR=1.20,95% CI:1.05-1.37,I=0%)。meta 回归分析无显著差异,部分比较存在发表偏倚。
HA 联合 SLR 与中风后失语患者的语言能力改善和更高的有效率显著相关,HA 治疗时应特别谨慎,尤其是在眼颈部针刺时。(注册号:CRD42020154475)